Tambagel, Rhea Mae .

HRN: 22-48-00  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2025
CEFUROXIME 750MG (VIAL)
01/04/2025
01/11/2025
IV
750mg
Q8h
UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractBloodstreamIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: